RTW Investments, LP

Beta Bionics raised $100M on August 30, 2023

Investors: Sands Capital Management, Farallon Capital Management, Pura Vida Investments, Perceptive Advisors, Marshall Wace, Soleus Capital Management, L.P., Eventide Asset Management, LifeSci Venture Partners, Omega Funds and RTW Investments, LP

Taysha Gene Therapies raised $150M on August 14, 2023

Investors: Octagon Capital Advisors, GordonMD Global Investments LP, PBM Capital Group, RA Capital Management, L.P., TCG X, The Invus Group, B Capital Group and RTW Investments, LP

Milestone Pharmaceuticals, Inc. raised $125M on March 28, 2023

Investors: RTW Investments, LP

CARGO Therapeutics raised $200M on March 1, 2023

Investors: Nextech Invest, Perceptive Advisors, Red Tree Venture Capital, T. Rowe Price, Samsara BioCapital, Wellington Management, Third Rock Ventures and RTW Investments, LP

Oricell Therapeutics Co., Ltd. raised $45M on February 28, 2023

Investors: Qiming Venture Partners, Qatar Investment Authority and RTW Investments, LP

Apogee Therapeutics raised $149M on December 7, 2022

Investors: RA Capital Management, L.P., Perceptive Advisors, Wellington Management, OrbiMed Advisors and RTW Investments, LP

Immatics Biotechnologies raised $110M on October 10, 2022

Investors: Dellora Investments, Wellington Management, Sofinnova Ventures, Russia technology fund, Perceptive Advisors, Samsara BioCapital and RTW Investments, LP

Immunic Therapeutics raised $60M on October 10, 2022

Investors: Great Point Partners, Logos Global Management, LP, The Invus Group, Commodore Capital, LP, Parkman Healthcare Partners LLC, Vivo Capital and RTW Investments, LP

Allakos Inc raised $150M on September 19, 2022

Investors: TCG X, Vivo Capital, Commodore Capital, LP, Surveyor Capital, Logos Global Management, LP and RTW Investments, LP

Immunocore raised $140M on July 18, 2022

Investors: General Atlantic and RTW Investments, LP